A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations.

Archive ouverte

Lohmann, Ebba | Leclere, Laurence | de Anna, Francesca | Lesage, Suzanne | Dubois, Bruno | Agid, Yves | Dürr, Alexandra | Brice, Alexis | Renseigné, Non

Edité par CCSD ; Elsevier -

International audience. We evaluated the neurological and neuropsychological profiles and olfaction as presymptomatic markers in a large family with Parkinson disease (PD) caused by the G2019S mutation in the LRRK2 gene. Five affected family members, 14 asymptomatic mutation carriers and 15 non-carriers were compared. Patients had typical dopa-responsive PD, frequently associated with cognitive impairment. Asymptomatic carriers and non-carriers could not be distinguished because of their neuropsychological status, the presence of depression or olfactory impairment. We were therefore unable to identify a presymptomatic marker of LRRK2-related PD.

Consulter en ligne

Suggestions

Du même auteur

LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.

Archive ouverte | Lesage, Suzanne | CCSD

International audience. BACKGROUND: Mutations in leucine-rich repeat kinase 2 gene (LRRK2), particularly the G2019S mutation in exon 41, have been detected in familial and sporadic Parkinson disease (PD) cases. OBJE...

Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease.

Archive ouverte | Lesage, Suzanne | CCSD

BACKGROUND: Mutations in the LRRK2 gene, the most frequent of which is the G2019S mutation in exon 41, cause familial and sporadic Parkinson's disease (PD) with reduced penetrance. OBJECTIVES: To assess the frequency of the LRRK2 ...

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.

Archive ouverte | Lesage, Suzanne | CCSD

International audience. BACKGROUND: Mutations in the leucine-rich-repeat kinase 2 (LRRK2) gene have been identified in families with autosomal dominant Parkinson's disease (ADPD), the most common of which is the p.G...

Chargement des enrichissements...